Ontology highlight
ABSTRACT: Background
Recurrence following radical resection in patients with stage IB gastric cancer (GC) is not uncommon. However, whether postoperative adjuvant chemotherapy could reduce the risk of recurrence in stage IB GC remains contentious.Methods
We collected data on 2110 consecutive patients with pathologic stage IB (T1N1M0 or T2N0M0) GC who were admitted to 8 hospitals in China from 2009 to 2018. The survival of patients who received adjuvant chemotherapy was compared with that of postoperative observation patients using propensity score matching (PSM). Two survival prediction models were constructed to estimate the predicted net survival gain attributable to adjuvant chemotherapy.Findings
Of the 2110 patients, 1344 received adjuvant chemotherapy and 766 received po
SUBMITTER: Gao X
PROVIDER: S-EPMC10867760 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature